Pharmafile Logo
Pharmafocus logo
Advanced Search

cost-effectiveness

Showing 6 posts of 6 posts found.

Victoza

Novo Nordisk looks to HEOR data to back Victoza

November 11, 2015
Research and Development, Sales and Marketing Byetta, HEOR, Lyxumia, NHS, Novo Nordisk, Victoza, cost-effectiveness

A Novo Nordisk-sponsored study of the cost-effectiveness of three different injectable anti-diabetes drugs has found Victoza is a cheaper option …

News
NHS sign

Cancer Drugs Fund assessment to be handed over to NICE

July 22, 2015
Medical Communications, Research and Development CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, NHSE, NICE, cost effectiveness, cost-effectiveness

NICE will oversee the evaluation of Cancer Drugs Fund treatments in future, under new plans due for consultation by NHS …

News

Change is needed, concedes NICE chief, but defends record

November 30, 2010
Sales and Marketing Andrew Dillon, NHS reform, NICE, cost-effectiveness, health technology assessment, hta, value-based pricing

The chief executive of NICE acknowledges changes are needed in how drugs are assessed in the UK – including more …

Feature

NICE’s methods to be put under the spotlight

July 19, 2010
Sales and Marketing MRC, NICE, cost-effectiveness

The Medical Research Council has awarded £2.3 million for new research into the academic methods underpinning advice given by NICE …

News

German Health Minister attacks ‘pharma monopoly’

March 10, 2010
Sales and Marketing Germany, cost-effectiveness, price cuts, prices

German Health Minister Philipp Rösler wants to break pharma’s ‘monopolistic hold’ over the country by introducing price limits on new …

News

The Pharmafocus Interview: Elmar Schnee

January 6, 2009
Sales and Marketing EU, Germany, IQWIG, Merck Serono, cost-effectiveness

Germany's Merck has the kind of business model that investors warm to during times of recession. The company is the …

Feature
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026